FDA Inspection 1111704 — Sato Pharmaceutical Co., Ltd.
The FDA completed an inspection of Sato Pharmaceutical Co., Ltd. on Nov 7, 2019 in Hachioji. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2019
- Fiscal Year
- 2020
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Hachioji (Japan)